Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel finding-Reference-Cited by-同舟云学术

Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel finding

Published:2016-09-15 Issue:12 Volume:43 Page:1161-1166
ISSN:0303-6987
Container-title:Journal of Cutaneous Pathology
language:en
Short-container-title:J Cutan Pathol

Author:

Al-Rohil Rami N¹,Torres-Cabala Carlos A¹²,Patel Anisha²,Tetzlaff Michael T¹,Ivan Doina¹²,Nagarajan Priyadharsini¹,Curry Jonathan L¹²,Miranda Roberto N³,Duvic Madeleine²,Prieto Victor G¹²,Aung Phyu P¹

Affiliation:

1. Department of Pathology, Section of Dermatopathology; University of Texas MD Anderson Cancer Center; Houston TX USA

2. Department of Dermatology; University of Texas MD Anderson Cancer Center; Houston TX USA

3. Department of Hematopathology; University of Texas MD Anderson Cancer Center; Houston TX USA

Publisher

Wiley

Subject

Dermatology,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cup.12797/fullpdf

Reference17 articles.

1. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: a longitudinal analysis of the National Cancer Data Base from 1998 to 2011;Al-Hamadani;Am J Hematol,2015

2. Intracellular activation of SGN-35, a potent anti-CD30 antibody-drug conjugate;Okeley;Clin Cancer Res,2010

3. cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity;Francisco;Blood,2003

4. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications;Campo;Blood,2011

5. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma;Gascoyne;Blood,1999

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Drug Conjugates in Cancer Therapy: Challenges and Opportunities;Pharmaceutical Science Advances;2024-08

2. Anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma;Egyptian Journal of Dermatology and Venereology;2024-04-18

3. Antibody–drug conjugates in urothelial carcinoma: scientometric analysis and clinical trials analysis;Frontiers in Oncology;2024-03-14

4. Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice;Experimental Hematology & Oncology;2024-03-01

5. Loss of or decrease in CD30 expression in four patients with anaplastic large cell lymphoma after brentuximab vedotin-containing therapy;Virchows Archiv;2024-02-13